Healthcare provider profile · identity verified

James W Badman, MD

Family Practice · ALTAMONTE SPRINGS, FL · NPI 1265470405

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	512	162
Rosuvastatin Calcium	Rosuvastatin Calcium	477	148
Levothyroxine Sodium	Levothyroxine Sodium	453	133
Amlodipine Besylate	Amlodipine Besylate	444	136
Alprazolam	Alprazolam	213	56
Metformin Hcl Er	Metformin Hcl	188	56
Lisinopril	Lisinopril	175	55
Zolpidem Tartrate	Zolpidem Tartrate	174	33
Gabapentin	Gabapentin	170	51
Trazodone Hcl	Trazodone Hcl	161	62
Tamsulosin Hcl	Tamsulosin Hcl	159	53
Pantoprazole Sodium	Pantoprazole Sodium	158	52
Escitalopram Oxalate	Escitalopram Oxalate	156	59
Losartan Potassium	Losartan Potassium	145	45
Famotidine	Famotidine	141	50
Liothyronine Sodium	Liothyronine Sodium	132	33
Metoprolol Succinate	Metoprolol Succinate	132	42
Omeprazole	Omeprazole	116	38
Pravastatin Sodium	Pravastatin Sodium	110	34
Sertraline Hcl	Sertraline Hcl	110	37
Simvastatin	Simvastatin	109	32
Duloxetine Hcl	Duloxetine Hcl	104	34
Fluticasone Propionate	Fluticasone Propionate	103	59
Mounjaro	Tirzepatide	100	14
Bupropion Xl	Bupropion Hcl	98	30
Olmesartan Medoxomil	Olmesartan Medoxomil	97	32
Carvedilol	Carvedilol	96	31
Ezetimibe	Ezetimibe	93	33
Fluoxetine Hcl	Fluoxetine Hcl	90	31
Buspirone Hcl	Buspirone Hcl	89	42
Allopurinol	Allopurinol	86	27
Metformin Hcl	Metformin Hcl	84	30
Finasteride	Finasteride	83	26
Benazepril Hcl	Benazepril Hcl	81	25
Metoprolol Tartrate	Metoprolol Tartrate	81	27
Lorazepam	Lorazepam	79	14
Tramadol Hcl	Tramadol Hcl	77	19
Albuterol Sulfate Hfa	Albuterol Sulfate	74	45
Meloxicam	Meloxicam	74	29
Montelukast Sodium	Montelukast Sodium	72	24
Valsartan	Valsartan	71	21
Donepezil Hcl	Donepezil Hcl	66	20
Eliquis	Apixaban	61	16
Ropinirole Hcl	Ropinirole Hcl	61	14
Clonazepam	Clonazepam	57	19
Alendronate Sodium	Alendronate Sodium	56	20
Jardiance	Empagliflozin	56	16
Fenofibrate	Fenofibrate	55	16
Ozempic	Semaglutide	55	14
Potassium Chloride	Potassium Chloride	55	19
Quetiapine Fumarate	Quetiapine Fumarate	55	17
Atenolol	Atenolol	53	19
Diazepam	Diazepam	53	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	53	13
Citalopram Hbr	Citalopram Hydrobromide	52	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	52	41
Synthroid	Levothyroxine Sodium	52	13
Testosterone	Testosterone	50	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	18
Methylphenidate Hcl	Methylphenidate Hcl	47	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	47	14
Progesterone	Progesterone, Micronized	47	15
Hydrochlorothiazide	Hydrochlorothiazide	45	16
Pioglitazone Hcl	Pioglitazone Hcl	44	12
Azithromycin	Azithromycin	43	41
Clopidogrel	Clopidogrel Bisulfate	43	13
Clonidine Hcl	Clonidine Hcl	36	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	36	suppressed
Ramipril	Ramipril	36	11
Azelastine Hcl	Azelastine Hcl	34	18
Estradiol	Estradiol	34	14
Methylprednisolone	Methylprednisolone	32	29
Trulicity	Dulaglutide	32	suppressed
Glimepiride	Glimepiride	31	12
Valacyclovir	Valacyclovir Hcl	30	16
Pregabalin	Pregabalin	29	suppressed
Anastrozole	Anastrozole	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	11
Doxycycline Hyclate	Doxycycline Hyclate	26	24
Estradiol (Twice Weekly)	Estradiol	26	suppressed
Furosemide	Furosemide	26	12
Baclofen	Baclofen	25	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Methocarbamol	Methocarbamol	24	12
Testosterone Cypionate	Testosterone Cypionate	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	19
Celecoxib	Celecoxib	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	21
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	11
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Estradiol (Once Weekly)	Estradiol	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	11
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Prednisone	Prednisone	16	13
Primidone	Primidone	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Mupirocin	Mupirocin	15	11
Topiramate	Topiramate	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Nystatin	Nystatin	14	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	14	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Temazepam	Temazepam	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error